EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis

Robin Willixhofer, Elisabetta Salvioni, Nicolò Capra, Mauro Contini, Jeness Campodonico, Piergiuseppe Agostoni iD

Physiological Reports · 2025-05 · 13 (9)

DOI: 10.14814/phy2.70308 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Physiological Reports, online erschienen am 01.05.2025. Verfasst von Robin Willixhofer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro Cardiologico Monzino, IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Amyloidosis, Cardiomyopathies, Pulmonary Ventilation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione IEO-MONZINO, Italian Ministry of Health, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cardiac amyloidosis (CA) cardiopulmonary exercise testing (CPET) is underexplored. This study evaluated exercise limitations in CA using CPET, focusing on the ventilation‐to‐carbon dioxide production (VE/VCO 2 ) slope and peak oxygen uptake (VO 2 ). Seventeen studies involving 1505 patients were analyzed and systematically reviewed according to PRISMA reporting guidelines. Subgroup analyses assessed differences by diagnosis (ATTR vs. AL), CPET modality, and age. The cohort included 12% with AL, 80% with ATTR (23% hereditary [ATTRv], 70% wild‐type [ATTRwt], 7% unspecified), and 8% unidentified subtypes. VE/VCO 2 slope was elevated across ATTR subgroups: 38.4 (95% CI: 36.9–40.0, I 2 = 57%) in ATTRwt and 37.9 (95% CI: 35.1–40.7, I 2 = 70%) in ATTRv. ATTR patients were older than AL patients by 9.0 years (95% CI: 0.4–17.6, I 2 = 88%) and had a higher VE/VCO 2 slope: 2.5 (95% CI: 0.2–4.8, I 2 = 0%). CPET modality influenced peak VO 2 , which was lowest for treadmill exercise (13.7, 95% CI: 12.7–14.8, I 2 = 0%, mL/min/kg) compared to upright cycle ergometry (14.7, 95% CI: 14.3–15.1, I 2 = 33%) and semi‐recumbent cycle ergometry (14.5, 95% CI: 14.1–14.9, I 2 = 28%). A high VE/VCO 2 slope characterizes both ATTRwt and ATTRv, while AL patients are younger with lower VE/VCO 2 slope levels. Peak VO 2 in ATTR patients may depend on exercise modality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisCardiomyopathiesPulmonary VentilationHumansCarbon DioxideExercise TestOxygen Consumption

Stichwörter der Autor:innen

amyloidosiscardiomyopathyexercise testingheart failurerisk prediction

Substanzen

Carbon Dioxide

Autor:innen und Institutionen

  • Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Cento Cardiologico Monzino, L'unita di Biostatistica, IRCCS, Milan, Italy.

ORCID-Profile: Piergiuseppe Agostoni

Förderung

  • Fondazione IEO-MONZINO
  • Italian Ministry of Health
  • Ministero della Salute

Zitieren

APA

Willixhofer, R., Salvioni, E., Capra, N., Contini, M., Campodonico, J., & Agostoni, P. (2025). Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis. Physiological Reports, 13(9). https://doi.org/10.14814/phy2.70308

Vancouver

Willixhofer R, Salvioni E, Capra N, Contini M, Campodonico J, Agostoni P. Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis. Physiological Reports. 2025;13(9). doi:10.14814/phy2.70308

BibTeX
@article{Willixhofer2025,
  author = {Willixhofer, Robin and Salvioni, Elisabetta and Capra, Nicolò and Contini, Mauro and Campodonico, Jeness and Agostoni, Piergiuseppe},
  title = {Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis},
  journal = {Physiological Reports},
  year = {2025},
  volume = {13},
  number = {9},
  doi = {10.14814/phy2.70308}
}
Kostenlos starten →